A micromethod for quantitation of debrisoquine and 4-hydroxydebrisoquine in urine by liquid chromatography

Brazilian Journal of Medical and Biological Research

Volumn 33, Issue 5, 2000, Pages 509-514

  Pereira, V A ^a   Auler, J O ^a   Carmona, M J ^a   Mateus, F H ^a   Lanchote, V L ^a   Breimer, D D ^b   Santos, S R C J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

4 Hydroxydebrisoquine; CYP2D6; Debrisoquine; Debrisoquine test validation; HPLC F; Urinary excretion kinetics

Indexed keywords

4 HYDROXYDEBRISOQUINE; DEBRISOQUINE; DEBRISOQUINE 4 HYDROXYLASE; METOPROLOL; XENOBIOTIC AGENT;

ACCURACY; ARTICLE; CARDIOVASCULAR DISEASE; DRUG DETERMINATION; DRUG URINE LEVEL; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; XENOBIOTIC METABOLISM;

EID: 0034044385     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2000000500004     Document Type: Article

References (12)

1. Evans DAP, Mahgoub A, Sloan TP, Idle JR & Smith RL (1980). A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. Journal of Medical Genetics, 17: 102-105.
2. Leonard MS, Silas JH, Smith AJ & Tucker GT (1977). Determination of debrisoquine and its 4-hydroxy metabolite in biological f:uids by gas chromatography with flameionization and nitrogen-selective detection. Journal of Chromatography, 133: 161-166
3. Chan K (1988). Comparison of gas chromatographic and high-performance liquid Chromatographic assays for the determination of debrisoquine and its 4-hydroxy metabolite in human fluids Journal of Chromatography. B, Biomedical Applications, 425: 311-321.
4. Daumas L, Sabot JF, Vermeulen E, Clapot P, Allegre F & Pinatel H (1991). Determination of debrisoquine and metabolites in human urine by gas chromatography-mass spectrometry. Journal of Chromatography. B, Biomedical Applications, 570 89-97.
5. Duche JC, Barre J & Tillement JP (1987). Rapid liquid Chromatographic determination of debrisoquine and its hydroxy metabolite in human urine to define hydroxylation phenotypes. Journal of Chromatography. B, Biomedical Applications, 423: 340-343.
6. Johnson KA, Kolatkar V & Straka RJ (1990). Improved selectivity of a high-performance liquid chromatography assay for debrisoquine and its 4-hydroxy metabolite from urine. Therapeutic Drug Monitoring, 12: 478-480.
7. Moncrieff J (1988). Assay of debrisoquine and 4-hydroxydebrisoquine in urine by reversed-phase high-performance liquid chromatography using on-line sample clean-up on a standard isocratic Chromatograph. Journal of Chromatography. B, Biomedical Applications, 428: 178-182.
8. Wanwimolruk S & Ferry DG (1990). Rapid high-performance liquid Chromatographic method for the analysis of debrisoquine and 4-hydroxydebrisoquine in urine without derivatization. Journal of Liquid Chromatography, 13: 961-968.
9. Gibaldi M (1991). Biopharmaceutics and Clinical Pharmacokinetics. 4th edn Lea & Febiger, Philadelphia, 203-233.
10. Shargel L & Yu ABC (1999). Applied Biopharmaceutics & Pharmacokinetics. 4th edn. Appleton & Lange, Stamford, 325-352.
11. Ritschel WA (1986). Handbook and Basic Pharmacokinetics. 2nd edn. Drug Intelligence Publications, Hamilton, 284-295.
12. Frye RF & Branch RA (1996). Improved high-performance liquid Chromatographic determination of debrisoqume and 4-hydroxydebrisoquine in human urine following direct injection. Journal of Chromatography. B, Biomedical Applications, 677: 178-182.